Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study
Authors:
- I. Rivero BelenchónIBI. Rivero Belenchón
- C. Muñoz CalahorroCCC. Muñoz Calahorro
- I. Osmán GarcíaIGI. Osmán García
- P. Beardo VillarPVP. Beardo Villar
- C.B. Congregado RuízCRC.B. Congregado Ruíz
- B. San José Ruíz JiménezBJB. San José Ruíz Jiménez
- J. Campé BortoloJBJ. Campé Bortolo
- R. Llarena IbargurenRIR. Llarena Ibarguren
- J. Extramiana CamenoJCJ. Extramiana Cameno
- R.A. Medina LópezRLR.A. Medina López
- J.P. Pedraza SanchezJSJ.P. Pedraza Sanchez
- 15 November 2019
- journal article
- abstracts
- Published by Elsevier in European Urology Supplements
- Vol. 18 (11) , e3464